Lung Cancer Research

Extensive clinical trials focusing on both non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), evaluating novel immunotherapy combinations and targeted treatments.

  • Advanced stage treatments
  • Combination therapies
  • Immunotherapy approaches

Multiple studies investigating innovative treatment strategies for both early-stage and metastatic disease.

Breast Cancer Studies

Research focusing on hormone receptor-positive and HER2-negative breast cancer, exploring new therapeutic combinations and targeted treatments.

  • Advanced metastatic disease
  • Endocrine therapy resistance
  • Novel drug combinations

Investigations into treatments for both early-stage and advanced breast cancer with various molecular subtypes.

Head and Neck Cancer

Clinical trials evaluating immunotherapy combinations for treating squamous cell carcinoma of the head and neck, with focus on recurrent and metastatic disease.

  • First-line treatments
  • Novel immunotherapy approaches
  • Combination strategies

Studies examining innovative treatment approaches for various stages of head and neck cancer.